October 1, 2024
TOPLINE: A unique glycosylation signature on circulating antibodies is detectable in blood up to 6 years before a diagnosis of Crohn’s disease and could serve as […]
October 1, 2024
ORLANDO — Heat-related emergency department visits in children and teens more than doubled over the past decade in two Texas children’s hospitals, according to research presented […]
October 1, 2024
The US Food and Drug Administration has approved dupilumab as an add-on maintenance therapy for adults whose chronic obstructive pulmonary disease (COPD) is inadequately controlled with […]
October 1, 2024
The European Commission has approved the topical pan-JAK inhibitor delgocitinib for adults with moderate to severe hand eczema, for whom topical corticosteroids are inadequate or inappropriate, […]
October 1, 2024
Share on PinterestIs FluMist, the at-home nasal vaccine that was recently approved by the FDA, as effective at preventing illness as traditional flu shots? Michael Buckner/Getty […]
October 1, 2024
Share on PinterestSome viral ‘sleepmaxxing’ trends may help you get a better night’s sleep, while others can make insomnia worse. Sergey Mironov/Getty Images Sleepmaxxing is a […]
September 30, 2024
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (RO1) Receipt Date: June 25, 2019 FOA Number: RFA-FD-20-001 Funding Opportunity Purpose: The purpose of […]
September 30, 2024
OOPD Background: The FDA Office of Orphan Products Development (OOPD) was created to identify and promote the development of orphan products. Orphan products are drugs, biologics, […]
September 30, 2024
On September 27, 2024, the Food and Drug Administration granted traditional approval to selpercatinib (Retevmo, Eli Lilly and Company) for adult and pediatric patients 2 years […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623
Next page